Express Scripts Inc.
1 Express Way
St. Louis
Missouri
63121
United States
Tel: 314-996-0900
143 articles about Express Scripts Inc.
-
Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis
7/18/2018
eviCore Medical Benefit Management Opens New Provider Service Center
-
The U.S. Justice Department announced yesterday that it will not challenge the merger of CVS Health Corp and health insurer Aetna.
-
Representative Tom MacArthur, Express Scripts Experts Highlight Solutions for Combatting Opioid Epidemic
7/10/2018
MacArthur, Express Scripts leaders, and a family impacted by opioid addiction, highlight how the public and private sector can work together to fight opioid misuse
-
Express Scripts' Physician-Minded Solutions Deliver Greater Price Transparency, Medication Safety and Coordination of Care
6/7/2018
Industry leading, data-driven tools and programs help prescribers make the best therapy decisions for patients at the point-of-care [07-June-2018] ST. LOUIS, June 7, 2018 /PRNewswire/ -- A suite of high-impact, data-driven engagement programs from Express Scripts (NASDAQ: ESRX) are simplifying the prescribing experience for physicians and providers, helping t
-
Pharmacy Everywhere: Express Scripts and MedAvail Announce Collaboration to Make Pharmacy More Affordable and Convenient
6/6/2018
Collaboration to examine how automated, self-service pharmacy centers can provide insured, underinsured and uninsured patients with a more affordable and convenient pharmacy experience
-
Express Scripts to Provide Patients with Faster Path to Rare Disease Diagnosis and Treatment, in Collaboration with PinnacleCare
5/31/2018
New Rare Conditions Care Value Program expands support services to facilitate second opinion that can improve health outcomes, reduce wasteful spending
-
Just about every week has plenty of exciting news in the biopharmaceutical industry, and this week was no different. Here’s a brief look back at some of our top stories.
-
Express Scripts Announces 2018 First Quarter Results
5/2/2018
Express Scripts Holding Company announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share.
-
Express Scripts Ranked as a Top 50 Inclusive company by DiversityInc
5/2/2018
Express Scripts has earned recognition among the Top 50 inclusive companies in the nation by DiversityInc, it was announced today.
-
Sanofi and Regeneron made a deal with pharmacy benefits manager Express Scripts for their Praluent, making it the exclusive PCSK9 inhibitor on their national formulary, essentially locking Amgen’s Repatha out of that market segment.
-
Amgen’s New Products Deliver Double-Digit Growth While Facing Down Pricing Pressure for New Migra...
4/25/2018
In its first-quarter earnings report, Thousand Oaks, California-based Amgen cited total revenue for the quarter of $5.6 billion, up 2 percent compared to the first quarter of 2017. But the quarter’s earnings were driven by double-digit growth for new and recently launched products. -
"Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications
4/25/2018
Many Americans on medications for chronic diseases are not concerned about missing doses, resent their spouses/partners reminding them to take their medicine and think they do a better job than others at taking their medication as prescribed.
-
Another major healthcare buyout may be on the horizon. According to reports, Walmart may be in talks to buy health insurer Humana.
-
Express Scripts Endorses "Know the Lowest Price Act of 2018" and "Patient Right to Know Drug Prices Act"
3/16/2018
Express Scripts is against clawbacks and gag clauses, anti-patient practices that have been used by other pharmacy benefit managers.
-
The Wall Street Journal speculated today that it won't be long before drug manufacturers start consolidating in order to improve their bottom lines.
-
U.S. insurer Cigna is acquiring pharmacy benefits manager Express Scripts for approximately $67 billion.
-
Avista Capital Partners to Acquire Express Scripts' Subsidiary United BioSource
11/27/2017
Centerview Partners LLC acted as financial advisor and Bryan Cave LLP acted as legal counsel to Express Scripts.
-
Express Scripts to Cover Mylan's EpiPen, Exclude Rivals
8/1/2017
-
Collegium Announces The Addition Of Xtampza ER To Express Scripts’ Formulary
12/15/2016
-
Express Scripts Announces Pricing of Maximum Tender Offers
7/15/2016